Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients

From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supp...

Full description

Saved in:
Bibliographic Details
Published in:Journal of translational medicine 2010-11, Vol.8 (S1), p.I3-I3, Article I3
Main Authors: Aarntzen, EHJG, Lesterhuis, W J, Van Rossum, M, Adema, G J, Figdor, C F, Punt, CJA, De Vries, IJM
Format: Article
Language:English
Subjects:
Immunology
Invited Lecture Presentation
Life sciences
Medical research
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-b2943-cc7f7290709b4b47111c1a56893c39d0866c1db3f2b78efa123a3437e2eee1f83
container_end_page I3
container_issue S1
container_start_page I3
container_title Journal of translational medicine
container_volume 8
creator Aarntzen, EHJG
Lesterhuis, W J
Van Rossum, M
Adema, G J
Figdor, C F
Punt, CJA
De Vries, IJM
description From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supplemental Information:
doi_str_mv 10.1186/1479-5876-8-S1-I3
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6f274b6318a3449a9d5e5afecf47f127</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6f274b6318a3449a9d5e5afecf47f127</doaj_id><sourcerecordid>2503623921</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2943-cc7f7290709b4b47111c1a56893c39d0866c1db3f2b78efa123a3437e2eee1f83</originalsourceid><addsrcrecordid>eNp1kstu1DAUhiMEEqXwAOws9gHfEscbJFRukSqxmMLWcuzjqYfEDnYyEg_BO-N0qqojwcrH5_z-zs1V9Zrgt4R07TvChaybTrR1V-9I3bMn1cWD7-kj-3n1IucDxpQ3XF5Uf3Y_fagtJH8Ei5Z1ignlGYx33qAbZGAcM5oTWG8WZEYfvNEjiuti4gTIB2Qh2OSXot606KiN8UEvPgaUl9V6yJtqiMttues9oL7vkQ4W9T_QBKMOcdJoLg8gLPll9czpMcOr-_Oy-v75083V1_r625f-6sN1PVDJWW2McIJKLLAc-MAFIcQQ3bSdZIZJi7u2NcQOzNFBdOA0oUwzzgRQACCuY5dVf-LaqA9qTn7S6beK2qs7R0x7pVPpaQTVOir40DLSFQSXWtoGGu3AOC4coaKw3p9Y8zpMYE3pI-nxDHoeCf5W7eNRMYyFYG0BfDwBBh__AziPlNGrbZ9q26fq1I6onhXMm_s6Uvy1Ql7UIa4plDEqiSltBKO4iMhJZFLMOYF7SEOw2j7SP8B_AVPfvyg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902257320</pqid></control><display><type>article</type><title>Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Aarntzen, EHJG ; Lesterhuis, W J ; Van Rossum, M ; Adema, G J ; Figdor, C F ; Punt, CJA ; De Vries, IJM</creator><creatorcontrib>Aarntzen, EHJG ; Lesterhuis, W J ; Van Rossum, M ; Adema, G J ; Figdor, C F ; Punt, CJA ; De Vries, IJM</creatorcontrib><description>From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supplemental Information:</description><identifier>ISSN: 1479-5876</identifier><identifier>EISSN: 1479-5876</identifier><identifier>DOI: 10.1186/1479-5876-8-S1-I3</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Immunology ; Invited Lecture Presentation ; Life sciences ; Medical research</subject><ispartof>Journal of translational medicine, 2010-11, Vol.8 (S1), p.I3-I3, Article I3</ispartof><rights>2010 De Vries et al; licensee BioMed Central Ltd.</rights><rights>Copyright ©2010 De Vries et al; licensee BioMed Central Ltd. 2010 De Vries et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b2943-cc7f7290709b4b47111c1a56893c39d0866c1db3f2b78efa123a3437e2eee1f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007736/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/902257320?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,44589,53790,53792</link.rule.ids></links><search><creatorcontrib>Aarntzen, EHJG</creatorcontrib><creatorcontrib>Lesterhuis, W J</creatorcontrib><creatorcontrib>Van Rossum, M</creatorcontrib><creatorcontrib>Adema, G J</creatorcontrib><creatorcontrib>Figdor, C F</creatorcontrib><creatorcontrib>Punt, CJA</creatorcontrib><creatorcontrib>De Vries, IJM</creatorcontrib><title>Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients</title><title>Journal of translational medicine</title><description>From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supplemental Information:</description><subject>Immunology</subject><subject>Invited Lecture Presentation</subject><subject>Life sciences</subject><subject>Medical research</subject><issn>1479-5876</issn><issn>1479-5876</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kstu1DAUhiMEEqXwAOws9gHfEscbJFRukSqxmMLWcuzjqYfEDnYyEg_BO-N0qqojwcrH5_z-zs1V9Zrgt4R07TvChaybTrR1V-9I3bMn1cWD7-kj-3n1IucDxpQ3XF5Uf3Y_fagtJH8Ei5Z1ignlGYx33qAbZGAcM5oTWG8WZEYfvNEjiuti4gTIB2Qh2OSXot606KiN8UEvPgaUl9V6yJtqiMttues9oL7vkQ4W9T_QBKMOcdJoLg8gLPll9czpMcOr-_Oy-v75083V1_r625f-6sN1PVDJWW2McIJKLLAc-MAFIcQQ3bSdZIZJi7u2NcQOzNFBdOA0oUwzzgRQACCuY5dVf-LaqA9qTn7S6beK2qs7R0x7pVPpaQTVOir40DLSFQSXWtoGGu3AOC4coaKw3p9Y8zpMYE3pI-nxDHoeCf5W7eNRMYyFYG0BfDwBBh__AziPlNGrbZ9q26fq1I6onhXMm_s6Uvy1Ql7UIa4plDEqiSltBKO4iMhJZFLMOYF7SEOw2j7SP8B_AVPfvyg</recordid><startdate>20101125</startdate><enddate>20101125</enddate><creator>Aarntzen, EHJG</creator><creator>Lesterhuis, W J</creator><creator>Van Rossum, M</creator><creator>Adema, G J</creator><creator>Figdor, C F</creator><creator>Punt, CJA</creator><creator>De Vries, IJM</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20101125</creationdate><title>Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients</title><author>Aarntzen, EHJG ; Lesterhuis, W J ; Van Rossum, M ; Adema, G J ; Figdor, C F ; Punt, CJA ; De Vries, IJM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2943-cc7f7290709b4b47111c1a56893c39d0866c1db3f2b78efa123a3437e2eee1f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Immunology</topic><topic>Invited Lecture Presentation</topic><topic>Life sciences</topic><topic>Medical research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aarntzen, EHJG</creatorcontrib><creatorcontrib>Lesterhuis, W J</creatorcontrib><creatorcontrib>Van Rossum, M</creatorcontrib><creatorcontrib>Adema, G J</creatorcontrib><creatorcontrib>Figdor, C F</creatorcontrib><creatorcontrib>Punt, CJA</creatorcontrib><creatorcontrib>De Vries, IJM</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aarntzen, EHJG</au><au>Lesterhuis, W J</au><au>Van Rossum, M</au><au>Adema, G J</au><au>Figdor, C F</au><au>Punt, CJA</au><au>De Vries, IJM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients</atitle><jtitle>Journal of translational medicine</jtitle><date>2010-11-25</date><risdate>2010</risdate><volume>8</volume><issue>S1</issue><spage>I3</spage><epage>I3</epage><pages>I3-I3</pages><artnum>I3</artnum><issn>1479-5876</issn><eissn>1479-5876</eissn><abstract>From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supplemental Information:</abstract><cop>London</cop><pub>BioMed Central</pub><doi>10.1186/1479-5876-8-S1-I3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1479-5876
ispartof Journal of translational medicine, 2010-11, Vol.8 (S1), p.I3-I3, Article I3
issn 1479-5876
1479-5876
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6f274b6318a3449a9d5e5afecf47f127
source Publicly Available Content (ProQuest); PubMed Central
subjects Immunology
Invited Lecture Presentation
Life sciences
Medical research
title Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A41%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skin-derived%20tumor%20specific%20T%20cells%20predict%20clinical%20outcome%20in%20dendritic%20cell%20vaccination%20studies%20in%20both%20stage%20III%20and%20IV%20melanoma%20patients&rft.jtitle=Journal%20of%20translational%20medicine&rft.au=Aarntzen,%20EHJG&rft.date=2010-11-25&rft.volume=8&rft.issue=S1&rft.spage=I3&rft.epage=I3&rft.pages=I3-I3&rft.artnum=I3&rft.issn=1479-5876&rft.eissn=1479-5876&rft_id=info:doi/10.1186/1479-5876-8-S1-I3&rft_dat=%3Cproquest_doaj_%3E2503623921%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b2943-cc7f7290709b4b47111c1a56893c39d0866c1db3f2b78efa123a3437e2eee1f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902257320&rft_id=info:pmid/&rfr_iscdi=true